Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- Roth Capital analyst Adam Walsh initiated coverage on vTv Therapeutics Inc (NASDAQ:VTVT) with a Buy rating and announced a price target of $58. vTv Therapeutics shares closed at $33.54 on Thursday. See how other analysts view this stock.
- Cantor Fitzgerald analyst Manish Somaiya initiated coverage on MasTec Inc (NYSE:MTZ) with an Overweight rating and announced a price target of $274. MasTec shares closed at $244.57 on Thursday. See how other analysts view this stock.
- Citigroup analyst Filippo Falorni initiated coverage on elf Beauty Inc (NYSE:ELF) with a Buy rating and announced a price target of $110. e.l.f. Beauty shares closed at $95.34 on Thursday. See how other analysts view this stock.
- Ladenburg Thalmann analyst Kevin DeGeeter initiated coverage on Decoy Therapeutics Inc. (NASDAQ:DCOY) with a Buy rating and announced a price target of $2.5. Decoy Therapeutics shares closed at $0.7505 on Thursday. See how other analysts view this stock.
- Morgan Stanley analyst Christopher Snyder initiated coverage on Mirion Technologies, Inc. (NYSE:MIR) with an Equal-Weight rating and announced a price target of $29. Mirion Technologies shares closed at $26.69 on Thursday. See how other analysts view this stock.
Considering buying MTZ stock? Here’s what analysts think:
Photo via Shutterstock
Recent Comments